TheLancetOncol Profile Banner
The Lancet Oncology Profile
The Lancet Oncology

@TheLancetOncol

Followers
60K
Following
1K
Media
2K
Statuses
11K

The Lancet Oncology is the global leader in clinical oncology publishing peer-reviewed research and reviews, comment, news, and Commissions. IF=35·9.

London, NYC, Munich, Beijing
Joined June 2009
Don't wanna be here? Send us removal request.
@TheLancetOncol
The Lancet Oncology
25 days
📢Our Aug issue is now live: 📊Original research #prostatecancer, contraceptive use and #livercancer, #rectalcancer, #colorectalcancer, #myeloma, #hodgkinlymphoma, paediatric NS tumours, #breastcancer. 📖Reviews #endometrialcancer management, PET imaging
Tweet media one
1
4
24
@TheLancetOncol
The Lancet Oncology
7 hours
RT @TheLancet: The week beginning Aug 4 was the most dangerous, tragic week of RFK Jr’s tenure yet. A Lancet Editorial outlines why—unpack….
0
111
0
@grok
Grok
3 days
Join millions who have switched to Grok.
155
184
1K
@TheLancetOncol
The Lancet Oncology
3 days
RT @TheLancet: ✍️ Essay competition | We're inviting submissions for our annual #WakleyPrize. Put pen to paper and submit your work before….
0
8
0
@TheLancetOncol
The Lancet Oncology
3 days
RT @LancetDigitalH: NEW Research: Assessing genotype−phenotype correlations in colorectal cancer with #DeepLearning: a multicentre cohort s….
0
2
0
@TheLancetOncol
The Lancet Oncology
4 days
Thanks for taking part - 78% of you were correct! The answer was B) Malignant soft tissue tumour characterised by loss of INI1 nuclear expression; wide excision and consideration of adjuvant radiotherapy are recommended. 🖱️
Tweet card summary image
thelancet.com
A healthy 57-year-old female patient presented to Chang Gung Memorial Hospital (Kaohsiung, Taiwan) in February, 2025, with a 6-month history of a progressively enlarging wound on her left forearm....
0
0
2
@TheLancetOncol
The Lancet Oncology
8 days
RT @TheLancet: Routine AI assistance may lead to loss of skills in health professionals who perform colonoscopies, study suggests in @Lance….
0
22
0
@TheLancetOncol
The Lancet Oncology
10 days
Linked comment: Breaking the patient-reported outcome code in KRASG12C-mutated #colorectalcancer: clinical interpretation of CodeBreaK 300. By Lars Henrik Jensen.
0
0
1
@TheLancetOncol
The Lancet Oncology
10 days
🔴Online today: Health-related quality of life in patients with KRASG12C-mutated chemorefractory metastatic #colorectalcancer treated with sotorasib plus panitumumab or standard of care (CodeBreaK 300): results from a phase 3, randomised clinical trial.
Tweet media one
2
2
10
@TheLancetOncol
The Lancet Oncology
11 days
RT @TheLancet: A picture is worth a thousand words. 📸 If you've taken a photo that captures a powerful health story, we want to see it. E….
0
10
0
@TheLancetOncol
The Lancet Oncology
11 days
RT @LancetDigitalH: NEW Review: Value of #ArtificialIntelligence in neuro-oncology. Read it here: .
0
5
0
@TheLancetOncol
The Lancet Oncology
12 days
C. Vasculitis, which typically affects the extremities and is generally associated with a favourable prognosis. D. Pyoderma gangrenosum; management should include systemic corticosteroid therapy and evaluation for associated underlying disease.
1
1
4
@TheLancetOncol
The Lancet Oncology
12 days
A. Nontuberculous mycoinfection; acid-fast staining is indicated and long-term multidrug antibiotic therapy. B. Malignant soft tissue tumour characterised by loss of INI1 nuclear expression; wide excision and consideration of adjuvant radiotherapy are recommended.
1
0
2
@TheLancetOncol
The Lancet Oncology
12 days
Immunohistochemical staining is positive for cytokeratin and demonstrates loss of INI1 nuclear expression. Which of the following statements regarding the diagnosis and management is most accurate?
Tweet media one
1
0
0
@TheLancetOncol
The Lancet Oncology
12 days
🚨Clinical picture quiz: A 57-year-old woman presents with 6-month history of a nonhealing ulcerated plaque on her left forearm. A skin biopsy reveals infiltrative epithelioid and spindled cells with vesicular nuclei, arranged in fascicles and palisading around areas of necrosis.
1
0
2
@TheLancetOncol
The Lancet Oncology
14 days
🗞️News: Kenya adopts digitally enabled cancer-care model, Paul Adepoju reports. “This is just the beginning. What we're building is not just software. It's a system that puts people at the centre.” Lucy Mithu (Roche East Africa) told The Lancet Oncology.
0
2
8
@TheLancetOncol
The Lancet Oncology
16 days
Thanks for taking part - 46% of you were correct! The cause of pneumocephalus in this patient was B) basal cell carcinoma with local destruction of the bone.
0
0
1
@TheLancetOncol
The Lancet Oncology
16 days
RT @TheLancet: "There is clearly a crisis in research integrity that needs urgent action by all involved.". A new Comment introduces The La….
0
20
0
@TheLancetOncol
The Lancet Oncology
16 days
RT @LancetGastroHep: Our September 2025 issue is out now at . Content includes viral hepatitis, irritable bowel syn….
0
10
0
@TheLancetOncol
The Lancet Oncology
22 days
🚨Online today: Prognostic and predictive value of baseline PSMA-PET total tumour volume and SUVmean in metastatic castration-resistant #prostatecancer in #ENZAp (ANZUP1901): a substudy from a multicentre, open-label, randomised, phase 2 trial.
Tweet media one
Tweet media two
1
16
32
@TheLancetOncol
The Lancet Oncology
23 days
What is the most probable cause of pneumocephalus in this case? (see thread for image & clinical history). (A) Trauma.(B) Basal cell carcinoma with local destruction of the bone.(C) Colon cancer metastasis.(D) Local infection.
1
0
4
@TheLancetOncol
The Lancet Oncology
23 days
At clinical examination, the patient showed no neurological deficits. On the frontal part of his head, he had a wound from which a fluid was visibly pulsating. A CT of the brain was done and showed extensive pneumocephalus, with breakthrough osteolysis on the frontal left cranium
Tweet media one
1
0
1